Omalizumab treatment can increase the serum levels of vitamin D in patients with chronic spontaneous urticaria
[Objective] To investigate the effect of omalizumab treatment on circulating levels of 25(OH)D in patients with chronic spontaneous urticaria (CSU). [Methods] Thirty-six patients with CSU were treated with 300 mg of omalizumab once every 4 weeks for 3 months. Spearman rank correlation analysis was p...
Saved in:
| Main Authors: | MENG Zhen, TANG Yaping |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2025-03-01
|
| Series: | Pifu-xingbing zhenliaoxue zazhi |
| Subjects: | |
| Online Access: | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2025.03.003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01) -
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
by: Petek Üstün, et al.
Published: (2025-07-01) -
Progress in the application of omalizumab in the treatment of chronic inducible urticaria
by: CHEN Ziyan, et al.
Published: (2024-12-01) -
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
by: Riccardo Asero, et al.
Published: (2024-11-01) -
Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria
by: Fikriye Kalkan, et al.
Published: (2025-03-01)